Urine Testing Cups Market, By Product Type (Split-Key Drug Test Cups, Push Button Cups, Drug Test Cups With Temperature Strips, Adulteration Strips For Drug Testing Cups , All-In-One Drug Testing Cups, and Others), By Application (Drug Test and Temperature Test), By End User (Workplaces And Schools, Law Enforcement Agencies and Criminal Justice Systems, Personal Use, Drug Treatment Centers, Pain Management Centers, Hospitals, and Drug Testing Laboratories), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Urine testing cups are the urinalysis screening device. A urinalysis is a simple test that looks at a small sample of your urine.  It can help find problems that need treatment, including infections or kidney problems.  It can also help find serious diseases in the early stages, like kidney disease, diabetes, or liver disease.  A urinalysis is also called a “urine test.” The cups are used to collect urine samples and are also used to detect the presence of drug metabolites and their percentage or level in the body. It can also be used to monitor the temperature. Some of these cups are available in different versions and are capable of testing for 5-14 drugs simultaneously. 

COVID-19 Impact on the Market:

The COVID-19 pandemic has hindered various businesses in many ways. The lockdown and the restriction on traveling and transport have hampered industrial supplies. Even though urine testing cups are high in demand for various tests as the pandemic has increased the risk for the aging population. Thus, they need regular checkups more testing cups are required. However, due to the limited or the restricted transport, the demands are not met. This report will quantify the impact of this pandemic on the urine testing cups market.

Drug abuse and alcohol consumption are increasing across the globe. According to the United Nations Office on Drugs and Crime (UNODC), 0.6% of the global adult population suffers from drug use disorders. Due this many the demand for drug test has increased in many countries. Many companies as well as firm like sport competitions or tournament has made it compulsory to test for drug consumption and any sport personnel abusing drugs are disqualified. Therefore, the demand for the urine testing cups has increased thereby boosting the market.

Increase in Aging Population

With the increasing aging population, diseases are also increasing which requires regular checkups. Regular check-up therefore needs more testing cups. Therefore, the supplies for the urine cups have increased thereby boosting the global urine testing cups market.

Restraints:

Privacy Rights

Significant levels of government rules & regulations associated with privacy rights in some countries such as the U.S., France, and Spain hinder the growth of the market.

The global urine testing cups market is segmented based on the product type, application, end-user, and region.

Depending upon the product type, the global urine testing cups market is categorized into split-key drug test cups, push button cups, drug test cups with temperature strips, adulteration strips for drug testing cups, all-in-one drug testing cups, and others. Based on the application, the target market is segmented into drug tests and temperature tests. Based on the end-user, the target market is segmented into workplaces and schools, law enforcement agencies and criminal justice systems, personal use, drug treatment centers, pain management centers, hospitals, and drug testing laboratories.

Regional Insights:

Regionally, the overall industry is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global urine testing cups market as they provide customization to suit any specific or unique requirement and tailor-make reports as per request.

For instance, in 2016, Quest collaborated with Safeway to bring testing services to twelve stores of its stores in California, Maryland, Virginia, Texas, and Colorado. Further by the end of 2017, Quest, in partnership with Walmart, incorporated laboratory testing in about 15 of their locations in Texas and Florida.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029.  For the purpose of this study, has segmented the global urine testing cups market report based on the product type, application, end-user, and region.

Global Urine Testing Cups Market, By Product Type:

• Split-Key Drug Test Cups
• Push Button Cups
• Drug Test Cups with Temperature Strips
• Adulteration Strips for Drug Testing Cups
• All-In-One Drug Testing Cups
• Others

Global Urine Testing Cups Market, By Application:

• Drug Test
• Temperature Test

Global Urine Testing Cups Market, By End-user:

• Workplaces and Schools
• Law Enforcement Agencies and Criminal Justice Systems
• Personal Use
• Drug Treatment Centers
• Pain Management Centers
• Hospitals
• Drug Testing Laboratories

Global Urine Testing Cups Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of the Middle East & Africa

The key players operating in the global urine testing cups market include Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Alere, Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Drgerwerk AG & Co. KGaA, Siemens AG, Express Diagnostics Int'l Inc., Shimadzu Corporation and MPD, Inc.

For instance, in January 2019, the iCUP Rx Drug Screen, launched by Alere (Waltham, Massachusetts), delivers drug levels for five of the most commonly abused opioid-derived drugs. The second new test, the Sefria Drug Screening Kit, is the first and only available in-office product to enable physicians to monitor for the presence of fentanyl; the Sefria kit is available from Immunalysis Corporation, a division of Alere.

• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Alere, Inc.
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific, Inc.
• Drgerwerk AG & Co. KGaA
• Siemens AG
• Express Diagnostics Int'l Inc.
• Shimadzu Corporation
• MPD, Inc.